US Patent Issued to Amicus Therapeutics on April 7 for "Methods of treating Fabry disease in patients having a mutation in the GLA gene" (New Jersey Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,268, issued on April 7, was assigned to Amicus Therapeutics Inc. (Philadelphia).

"Methods of treating Fabry disease in patients having a mutation in the GLA gene" was invented by Elfrida Benjamin (Millstone Township, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods of treating a patient diagnosed with Fabry disease and methods of enhancing Alpha-galactosidase A in a patient diagnosed with or suspected of having Fabry disease. Certain methods comprise administering to a patient a therapeutically effective dose of a pharmacological chaperone for Alpha-galactosidase A, wherein the patient has a mutation in the nucleic acid seque...